Dangerous entanglements

Trends in Molecular Medicine

Volumn 12, Issue 6, 2006, Pages 235-237

  Kaufmann, William K ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 BIS(3,5 DIOXO 1 PIPERAZINYL)BUTANE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; GYRASE INHIBITOR;

CANCER CELL; CELL CYCLE G2 PHASE; CHROMATID EXCHANGE; CHROMOSOME ABERRATION; CLINICAL OBSERVATION; DISEASE COURSE; ENZYME MECHANISM; GENETIC STABILITY; HUMAN; INOCULATION; PRESERVATION; SHORT SURVEY; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL CYCLE; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOME ABERRATIONS; DNA TOPOISOMERASES, TYPE II; ENZYME INHIBITORS; ETOPOSIDE; G2 PHASE; GENOMIC INSTABILITY; HUMANS; PIPERAZINES; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 33745074915     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2006.04.001     Document Type: Short Survey

References (21)

1. Downes C.S., et al. A topoisomerase II-dependent G2 cycle checkpoint in mammalian cells. Nature 372 (1994) 467-470
2. Deming P.B., et al. The human decatenation checkpoint. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 12044-12049
3. Gimenez-Abian J.F., et al. Premitotic chromosome individualization in mammalian cells depends on topoisomerase II activity. Chromosoma 109 (2000) 235-244
4. Deming P.B., et al. ATR enforces the topoisomerase II-dependent G2 checkpoint through inhibition of Plk1 kinase. J. Biol. Chem. 277 (2002) 36832-36838
5. Damelin M., et al. Decatenation checkpoint deficiency in stem and progenitor cells. Cancer Cell 8 (2005) 479-484
6. Paulovich A.G., et al. When checkpoints fail. Cell 88 (1997) 315-321
7. Holm C. Coming undone: how to untangle a chromosome. Cell 77 (1994) 955-957
8. Haering C.H., and Nasmyth K. Building and breaking bridges between sister chromatids. Bioessays 25 (2003) 1178-1191
9. Losada A., and Hirano T. Intermolecular DNA interactions stimulated by the cohesin complex in vitro: implications for sister chromatid cohesion. Curr. Biol. 11 (2001) 268-272
10. Holm C., et al. DNA topoisomerase II must act at mitosis to prevent nondisjunction and chromosome breakage. Mol. Cell. Biol. 9 (1989) 159-168
11. Wang J.C. DNA topoisomerases. Annu. Rev. Biochem. 65 (1996) 635-692
12. Roca J., et al. Antitumor bisdioxopiperazines inhibit yeast DNA topoisomerase II by trapping the enzyme in the form of a closed protein clamp. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 1781-1785
13. Kaufmann W.K., and Kies P.E. DNA signals for G2 checkpoint response in diploid human fibroblasts. Mutat. Res. 400 (1998) 153-167
14. Clarke D.J., et al. Topoisomerase II inhibition prevents anaphase chromatid segregation in mammalian cells independently of the generation of DNA strand breaks. J. Cell Sci. 105 (1993) 563-569
15. Franchitto A., et al. The G2-phase decatenation checkpoint is defective in Werner syndrome cells. Cancer Res. 63 (2003) 3289-3295
16. Lou Z., et al. BRCA1 participates in DNA decatenation. Nat. Struct. Mol. Biol. 12 (2005) 589-593
17. Jackman M., et al. Active cyclin B1-Cdk1 first appears on centrosomes in prophase. Nat. Cell Biol. 5 (2003) 143-148
18. Kaufmann W.K., et al. Degradation of ATM-independent decatenation checkpoint function in human cells is secondary to inactivation of p53 and correlated with chromosomal destabilization. Cell Cycle 1 (2002) 210-219
19. Cervantes R.B., et al. Embryonic stem cells and somatic cells differ in mutation frequency and type. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 3586-3590
20. Doherty S.C., et al. Cell cycle checkpoint function in bladder cancer. J. Natl. Cancer Inst. 95 (2003) 1859-1868
21. Nakagawa T., et al. Identification of decatenation G2 checkpoint impairment independently of DNA damage G2 checkpoint in human lung cancer cell lines. Cancer Res. 64 (2004) 4826-4832